Clinical study of new tumor specificity trace of 18F-FAPI PET/CT guide proton and heavy ion precision radiotherapy

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000036091

Enrollment

Unknown

Registered

2020-08-21

Start date

2020-10-01

Completion date

Unknown

Last updated

2020-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cancer

Interventions

Case series:no

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Sign the informed consent form; 2) Aged >=18 years old; 3) Ability to follow the plan; 4) Patients who intend to undergo particle radiotherapy; 5) Those who can cooperate during PET/CT inspection and successfully complete the inspection process.

Exclusion criteria

Exclusion criteria: 1) Those who have a history of other malignant tumors; 2) Those who do not sign the informed consent; 3) Patients who fail to complete the PET/CT examination within the prescribed time limit; 4) Those who withdraw from clinical research.

Design outcomes

Primary

Measure	Time frame
therapy outcome;coincidence rate;	—

Countries

China

Contacts

Public ContactJingyi Cheng

Shanghai Proton and Heavy Ion Center

jingyi.cheng@sphic.org.cn+86 18017312573

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 9, 2026